German ophthalmic device-maker Implandata Ophthalmic Products said it raised €3 million (about $3.8 million) in its latest funding round and established a Delaware-based subsidiary to help launch its lead product in the U.S.
Funding Roundup
Sinopsys Surgical gains $8.3M funding round for sinusitis device | Medtech funding for the week of October 20, 2014
Report: EndoStim tables IPO
EndoStim, citing poor market conditions, has tabled its initial public offering it hoped would raise nearly $36 million for its neurostimulation device for gastroesophageal reflux disease, according to Renaissance Capital.
EndoStim had planned to put $10 million of the IPO’s proceeds into clinical studies and another $14 million to commercialize the system.
Stealth hypertension startup Sympara Medical raises nearly $6m
Sensory Medical raises $1.4m for Relaxis restless legs treatment
Sensory Medical shook a leg on a 2nd tranche of funding since receiving FDA clearance last spring for its device to relieve symptoms of restless legs syndrome, reporting $1.4 million in fresh funding on the heels of a $1 million tranche in June.
Medrobotics taps backers for $20m
Medrobotics said it closed on $20 million in new funding in a preferred stock sale to prior backers as plans to expand its commercial footprint in Europe.
Raynham, Mass.-based Medrobotics also said that it’s "met all applicable FDA requirements" to distribute its Flex Retractor in the U.S.
ZipLine Medical adds $5.7m to Series C round
ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People’s Republic.
Breast implant maker Sientra sets IPO range
Breast implant maker Sientra set a price range for its planned initial public offering and raised the upper limit to $92 million, after filing in mid-September for an $86 million IPO.
Sinopsys Surgical sniffs up $8.3m for sinusitis device
Stealth-mode startup Sinopsys Surgical said it raised $8.3 million in an equity funding round for the technique it’s developing to repurpose the tear duct to drain into the sinuses as a way to relieve chronic sinusitis.
CEO Dr. Harry Ross was a partner with Aweida Venture Partners of Superior, Colo., near to Sinopsys Surgical’s Boulder headquarters.
Astute Medical to receive up to $30M from CRG for kidney-injury test | Medtech funding for the week of October 13, 2014
MID Labs lands $51m for eye surgery devices
MID Labs Ltd. said today that it raised a $51 million funding round for its eye surgery devices it plans to use to expand in the U.S. and China.
The round, led by OrbiMed and Frontline BioVentures, also included Softbank China Venture Capital, Allen Chao and Sungent BioVenture, according to a press release.